ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
ALX ONCOLOGY HOLDINGS reports 2023 executive compensation
By ExecPay News
Published: April 22, 2024
ALX ONCOLOGY HOLDINGS reported fiscal year 2023 executive compensation information on April 22, 2024.
In 2023, four executives at ALX ONCOLOGY HOLDINGS received on average a compensation package of $2.6M, a 2% increase compared to previous year.
Average pay of disclosed executives at ALX ONCOLOGY HOLDINGS
Jason Lettmann, Chief Executive Officer, received $4.9M in total. 90% of Lettmann's compensation, or $4.4M, was in option awards. Lettmann also received $119K in non-equity incentive plan, $217K in salary, as well as $151K in other compensation.
Jaume Pons, Chief Executive Officer, received a compensation package of $2.7M, which decreased by 26% compared to previous year. 44% of the compensation package, or $1.2M, was in option awards.
Sophia Randolph, Chief Medical Officer, earned $1.4M in 2023, a 34% decrease compared to previous year.
Peter Garcia, Chief Financial Officer, received $1.3M in 2023, which decreases by 26% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 22, 2024.